CHU Sud

Amiens 80054

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Relapsed or Refractory Chronic Lymphocytic Leukemia

Studies at this site

• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
• Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia — Completed